ArticleFuture oncology (London, England)2026
Impact of antiemetic prophylaxis on reducing trastuzumab deruxtecan dose modifications in HER2+/HER2-low breast cancer.
Junghoon Shin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.